Old Web
Fulvestrant plus capivasertib versus placebo in metastatic ER positive breast cancer (FAKTION): a randomised, double-blind, placebo-controlled, phase II trial
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI